Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.
NYS Entity Status
NYS Filing Date
JULY 15, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - GOLDEN PHARMACEUTICAL, INC.
AROUND THE WEB
- A Drug Maker Spends Big in Washington to Make Itself Heard
By JAY HANCOCK, ELIZABETH LUCAS and SYDNEY LUPKIN - Friday Jul 21, 2017
- Police Criticize Trump for Urging Officers Not to Be ‘Too Nice’ With Suspects
By BRIAN M. ROSENTHAL - Saturday Jul 29, 2017
Law enforcement officials condemned the president’s remarks as inappropriate and potentially dangerous. Police supporters said it was clearly intended as a joke.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- Trump to Police: 'Don't Be Too Nice'
Friday Jul 28, 2017
President Donald Trump suggested police should take a rougher approach with people suspected of crimes, in remarks to law enforcement officials in Brentwood, N.Y., about combatting gang activity and illegal immigration. Photo: Getty
- Considering the Side Effects of Drugmakers’ Money-Back Guarantees
By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017
The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.